In this cohort study of 1 136 016 patients from the National Cancer Database in the US, the proportions of ERBB2-low breast cancer were slightly lower among Hispanic and non-Hispanic Black patients compared with non-Hispanic White patients. Here, ERBB2 is linked to breast carcinoma.